Predictive factors for response to lamivudine in chronic hepatitis B

Revista do Instituto de Medicina Tropical de Sao Paulo

Volumn 42, Issue 4, 2000, Pages 189-196

  Da Silva, Luiz Caetano ^a   Da Fonseca, Luís Edmundo Pinto ^a,d   Carrilho, Flair José ^a   Alves, Venâncio Avancini Ferreira ^a,b   Sitnik, Roberta ^c   Pinho, João Renato Rebello ^b,c  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b INSTITUTO ADOLFO LUTZ   (Brazil)

^c Jardim Paulista   (Brazil)

^d NONE   (Brazil)

Author keywords

bDNA; HBV; HBV DNA; Hepatitis B; Lamivudine; PCR

Indexed keywords

HEPATITIS B CORE ANTIGEN; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; VIRUS DNA;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CHRONIC HEPATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; FEMALE; HEPATITIS B; HUMAN; MALE; PREDICTION; PROSPECTIVE STUDY; RISK FACTOR; TREATMENT OUTCOME; VIRUS LOAD; VIRUS MUTATION; VIRUS REPLICATION;

EID: 0033865357     PISSN: 00364665     EISSN: None     Source Type: Journal    
DOI: 10.1590/s0036-46652000000400003     Document Type: Article

References (37)

1. AYE, T.T.; BARTHOLOMEUSZ, A; SHAW, T. et al. - Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J. Hepat., 26: 1148-1153, 1997.
2. BARTHOLOMEW, M.M.; JANSEN, R.W.; JEFFERS, L.J. et al. - Hepatitis-B-virus resistance to lamivudine given for recurrent infection after orthotopic liver transplantation. Lancet, 349: 20-22, 1997.
3. BENHAMOU, Y.; KATLAMA, C.; LUNEL, F. et al. - Effects of lamivudine on replication of hepatitis B virus in HIV-infected men. Ann. intern. Med., 125: 705-712, 1996.
4. BUTTERWORTH, L.-A.; PRIOR, S.L.; BUDA, P.J. et al. - Comparison of four methods for quantitative measurement of hepatitis B viral DNA. J. Hepat., 24: 686-691, 1996.
5. CHAYAMA, K.; SUZUKI, Y.; KOBAYASHI, M. et al. - Emergence and takeover of YMDD motif mutant hepatitis B virus during long-term lamivudine therapy and re-takeover by wild type after cessation of therapy. Hepatology, 27: 1711-1716, 1998.
6. DIENSTAG, J.L.; PERRILLO, R.P.; SCHIFF, E.R. et al. - A preliminary trial of lamivudine for chronic hepatitis B infection. New Engl. J. Med., 333: 1667-1661, 1995.
7. DIENSTAG, J.L.; SCHIFF, E.R.; MITCHELL, M. et al. - Extended lamivudine retreatment for chronic hepatitis B. Hepatology, 24: 188A, 1996 [Abstract].
8. DUSHEIKO, G.M. - New treatments for chronic viral hepatitis B. In: ARROYO, V.; BOSCH, J.; BRUGUERA, M. & RODÉS, J., ed. Therapy in liver diseases: the pathophysioligical basis of therapy. Barcelona, Masson, 1997, p. 317-330.
9. GARRETT, L.; DIENSTAG, J.L.; GAUTHIER, J. et al. - Hepatitis B e-antigen (HBeAg) seroconversion in two patients with evidence of genotypic resistance following extended lamivudine treatment. Hepatology, 26: 431A, 1997 [Abstract].
10. HADZIYANNIS, S.J. - Natural course and therapy of anti-HBe-positive chronic hepatitis B. In: ARROYO, V.; BOSCH, J.; BRUGUERA, M. & RODÉS, J., ed. Therapy in liver diseases. The pathophysiological basis of therapy. Barcelona, Masson, 1997. p. 301-308.
11. HONKOOP, P.; DE MAN R.A.; ZONDERVAN, P.E. et al. - Histological improvement in patients with chronic hepatitis B virus infection treated with lamivudine. Liver, 17: 103-106, 1997.
12. HONKOOP, P.; DE MAN R.A.; NIESTERS, H.G.M. et al. - Quantitative hepatitis B virus DNA assessment by the limiting-dilution polymerase chain reaction in chronic hepatitis B patients: evidence of continuing viral suppression with longer duration and higher dose of lamivudine therapy. J. viral Hepatitis, 5: 307-312, 1998.
13. HONKOOP, P.; NIESTERS, H.G.; DE MAN R.A. et al. - Lamivudine resistance in immunocompetent chronic hepatitis B. Incidence and patterns. J. Hepat., 26: 1393-1395, 1997.
14. HONKOOP, P.; DE MAN, R.A.; NIESTERS, H.G.M. et al. - Incidence, characteristics and clinical impact of lamivudine resistance in chronic hepatitis B. J. Hepat., 28(suppl. 1): 48, 1998 [Abstract].
15. KANEKO, S.; FEINSTONE, S.M. & MILLER, R.H. - Rapid and sensitive method for the detection of serum hepatitis B virus DNA using the polymerase chain reaction technique. J. clin. Microbiol., 27: 1930-1933, 1989.
16. KANEKO, S.; MILLER, R.H.; DI BISCEGLIE, A.M. et al. - Detection of hepatitis B virus DNA in serum by polymerase chain reaction. Application for clinical diagnosis. Gastroenterology, 99: 799-804, 1990.
17. KAPKE, G.E.; WATSON, G.; SHEFFLER, S. et al. - Comparison of the Chiron Quantiplex branched DNA (bDNA) assay and the Abbott Genostics solution hybridization assay for quantification of hepatitis B viral DNA. J. viral Hepatitis, 4: 67-75, 1997.
18. KROGSGAARD, K.; MARCELLIN, P.; TREPO, C. et al. - Prednisolone withdrawal therapy enhances the effect of human lymphoblastoid interferon in chronic hepatitis B. J. Hepat., 25: 803-813, 1996.
19. KWOK, S. & HIGUCHI, R. - Avoiding false positives with PCR. Nature (Lond.), 339: 237-238, 1989.
20. LAI, C.-L.; CHIEN, R.-N.; LEUNG, N.W.Y. et al. - A one-year trial of lamivudine for chronic hepatitis B. New Engl. J. Med., 339: 61-68, 1998.
21. LAU, D.T.-Y.; DOO, E.; GHANY, M.G. et al. - Lamivudine for chronic hepatitis B with typical and atypical serology. Hepatology, 26: 429A, 1997 [Abstract].
22. LING, R.; MUTIMER, D.; AHMED, M. et al. - Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology, 24:711-713, 1996.
23. MARKOWITZ, J.; PAKRASI, A.; HOLLIS, P. et al. - Efficacy of lamivudine for prophylaxis and treatment of hepatitis B in liver transplant patients. Hepatology, 24: 182A, 1996 [Abstract].
24. MUTIMER, D.; PILLAY, D.; DRAGON, E. et al. - High pre-treatment serum hepatitis B virus titre predicts failure of lamivudine prophylaxis and graft re-infection after liver transplantation. J. Hepat., 30: 715-721, 1999.
25. NAOUMOV, N. V.; CHOKSHI, S.; SMITH, H.M. et al. - Emergence and characterization of lamivudine-resistant hepatitis B virus variant. Hepatology, 24: 282A, 1996 [Abstract].
26. NEVENS, F.; MAIN, J.; HONKOOP, P. et al. - Lamivudine therapy for chronic hepatitis B: a six-month randomized dose-ranging study. Gastroenterology, 113: 1258-1263, 1977.
27. NIITSUMA, H.; ISHII, M.; MIURA, M. et al. - Low level hepatitis B viremia detected by polymerase chain reaction accompanies the absence of HBe antigenemia and hepatitis in hepatitis B virus carriers. Amer. J. Gastroent., 92: 119-123, 1997.
28. PERRILLO, R.; RAKELA, J.; MARTIN, P. et al. - Lamivudine for hepatitis B after liver transplantation. Hepatology, 24: 182A, 1996 [Abstract].
29. PERRILLO, R.P. - Antiviral therapy of transplant patients with recurrent hepatitis B. In: ARROYO, V.; BOSCH, J.; BRUGUERA, M. & RODÉS, J., ed. Therapy in liver diseases: the pathophysiological basis of therapy. Barcelona, Masson, 1997. p. 347-350.
30. PUGH, R.N.; MURRAY-LYON, I.M.; DAWSON, J.L. et al. - Transection of the oesophagus for bleeding oesophageal varices. Brit. J. Surg., 60: 646-649, 1973.
31. ROSENSTRAUS, M.; GUTEKUNST, K. & DALE, B. - Utility of hepatitis virus nucleic acid assays in therapeutic drugs trials. In: SCHINAZI, R.F.; SOMMADOSSI, J.-P. & THOMAS, H.C., ed. Therapies for viral Hepatitis. London, International Medical Press, 1998. p 115-127.
32. SANTOS, R.T.M.; ALVES, V.A.F.; WAKAMATSU, A. et al. - Chronic hepatitis B immunohistochemistry - comparison of the amplification systems PAP and ABC for the detection of HBsAg and HBcAg. Arch. argent. Enferm. Apar. dig., 10: 10, 1996.
33. TASSOUPOULOS, N.C.; VOLPES, R.; PASTORE, G. et al. - Efficacy of lamivudine in patients with hepatitis B e antigen - negative / hepatitis B virus DNA - positive (precore mutant) chronic hepatitis B. Hepatology, 29: 889-896, 1999.
34. WONG, D.K.H.; CHEUNG, A.M.; O'ROURKE, K. et al. - Effect of alpha-interferon treatment in patients with hepatitis B e antigen-positive chronic hepatitis B: a meta-analysis. Ann. intern. Med., 119: 312-323, 1993.
35. WONG, W.W.S. & TYRRELL, D.L.J. - Treatment of hepatitis B virus with lamivudine. In: SCHINAZI, R.F.; SOMMADOSSI, J.-P. & THOMAS, H.C., ed. Therapies for viral Hepatitis. London, International Medical Press, 1998. p. 353-363.
36. YOTSUYANAGI, H.; YASUDA, K.; IINO, S. et al. - Persistent viremia after recovery from self-limited acute hepatitis B. Hepatology, 27: 1377-1382, 1998.
37. ZEUZEM, S.; DE MAN, R.A.; HONKOOP, P. et al. - Dynamics of hepatitis B virus infection in vivo. J. Hepat., 27: 431-436, 1997.